Non-invasive prenatal testing in Germany: a unique ethical and policy landscape

Non-invasive prenatal testing (NIPT) has been available commercially in Europe since approximately 2012. Currently, many countries are in the process of integrating NIPT into their publicly funded healthcare systems to screen for chromosomal aneuploidies such as trisomy 21 (Down syndrome), with a va...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowman-Smart, Hilary, Wiesemann, Claudia, Horn, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172332/
https://www.ncbi.nlm.nih.gov/pubmed/36509835
http://dx.doi.org/10.1038/s41431-022-01256-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172332/
https://www.ncbi.nlm.nih.gov/pubmed/36509835
http://dx.doi.org/10.1038/s41431-022-01256-x

Ejemplares similares